AU2000278445A1 - Tea catechin formulations and processes for making same - Google Patents

Tea catechin formulations and processes for making same

Info

Publication number
AU2000278445A1
AU2000278445A1 AU2000278445A AU7844500A AU2000278445A1 AU 2000278445 A1 AU2000278445 A1 AU 2000278445A1 AU 2000278445 A AU2000278445 A AU 2000278445A AU 7844500 A AU7844500 A AU 7844500A AU 2000278445 A1 AU2000278445 A1 AU 2000278445A1
Authority
AU
Australia
Prior art keywords
processes
making same
tea catechin
catechin formulations
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000278445A
Inventor
Raymond Cooper
D. James Morre
Dorothy M Morre
Howard Sun
Qing Ye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmanex Inc
Purdue Research Foundation
Original Assignee
Pharmanex Inc
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/537,211 external-priority patent/US6410061B1/en
Application filed by Pharmanex Inc, Purdue Research Foundation filed Critical Pharmanex Inc
Publication of AU2000278445A1 publication Critical patent/AU2000278445A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2000278445A 2000-03-29 2000-10-02 Tea catechin formulations and processes for making same Abandoned AU2000278445A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09537211 2000-03-29
US09/537,211 US6410061B1 (en) 1999-03-30 2000-03-29 Tea catechins as cancer specific proliferation inhibitors
US09640768 2000-08-17
US09/640,768 US6428818B1 (en) 1999-03-30 2000-08-17 Tea catechin formulations and processes for making same
PCT/US2000/027087 WO2001072319A1 (en) 2000-03-29 2000-10-02 Tea catechin formulations and processes for making same

Publications (1)

Publication Number Publication Date
AU2000278445A1 true AU2000278445A1 (en) 2001-10-08

Family

ID=27065414

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000278445A Abandoned AU2000278445A1 (en) 2000-03-29 2000-10-02 Tea catechin formulations and processes for making same

Country Status (3)

Country Link
US (1) US6428818B1 (en)
AU (1) AU2000278445A1 (en)
WO (1) WO2001072319A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696484B2 (en) 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
JP4738592B2 (en) 1997-10-31 2011-08-03 アーチ・デヴェロップメント・コーポレイション Methods and compositions for modulating 5α-reductase activity
DE60031921T2 (en) * 1999-08-16 2007-09-20 Dsm Ip Assets B.V. Process for the preparation of epigallocatechin gallate
KR100371971B1 (en) * 1999-09-30 2003-02-14 주식회사 펩트론 A Chemical Library Preparation Method from Natural Product
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
DE60320527T2 (en) * 2002-02-05 2009-06-10 Kao Corp. PROCESS FOR THE PREPARATION OF GREEN TEEPOLYPHENOL
EP2260845A3 (en) * 2002-06-21 2012-08-22 L'Oréal Use of polyphenols for the treatment of alopecia
WO2004009078A1 (en) * 2002-07-24 2004-01-29 The Board Of Trustees Of The University Of Illinois Cancer chemopreventative compounds and compositions and methods of treating cancers
US6953786B2 (en) * 2002-10-01 2005-10-11 The Regents Of The University Of California Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
US7115283B2 (en) * 2003-05-06 2006-10-03 Access Business Group International Llc Preparations for sustained release of nutraceuticals and methods of controllably releasing nutraceuticals
WO2005009434A2 (en) 2003-06-25 2005-02-03 The Burnham Institute Compounds and methods for inducing apoptosis in cancer cells
US20050008712A1 (en) * 2003-07-08 2005-01-13 Debasis Bagchi Compositions incorporating high-caffeine green tea extract and related methods for promoting healthy body weight
KR20060121887A (en) * 2003-09-23 2006-11-29 디에스엠 아이피 어셋츠 비.브이. Compositions for the treatment and prevention of diabetes mellitus
EP2491939B1 (en) 2004-01-12 2017-09-20 ISP Investments LLC Bioactive compositions from theacea plants and processes for their production and use
EP1725247A4 (en) * 2004-01-23 2010-04-28 Ohio Med College Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation
CN1997356A (en) * 2004-04-23 2007-07-11 安姆根有限公司 Sustained release formulations
EP1817023A4 (en) * 2004-11-16 2010-08-18 Limerick Biopharma Inc Methods and compositions for treating pain
US20070087977A1 (en) * 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
US8029829B2 (en) * 2005-02-03 2011-10-04 Taiyo Kagaku Co., Ltd. Preventive, relieving or therapeutic composition for diabetes mellitus and/or diabetic nephropathy
CA2600276C (en) 2005-03-08 2013-01-08 Mitsui Norin Co., Ltd Polyphenol coxib combinations and methods
US8287923B2 (en) * 2005-06-10 2012-10-16 Medical College Of Georgia Research Institute, Inc. Compositions and methods for treating immune disorders
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
EP1922067A1 (en) * 2005-08-11 2008-05-21 Medical College Of Georgia Research Institute Modified green tea polyphenol formulations
US7491413B2 (en) 2005-09-30 2009-02-17 Purdue Research Foundation Compositions and methods for treating and preventing virus infections
CN1837169A (en) * 2006-03-14 2006-09-27 房学迅 Compound capable of inhibiting zinc ion metalloproteinases
JP4569965B2 (en) * 2006-04-17 2010-10-27 花王株式会社 Method for producing purified green tea extract
JP4562682B2 (en) * 2006-04-17 2010-10-13 花王株式会社 Method for producing purified green tea extract
JP4977523B2 (en) * 2006-05-09 2012-07-18 花王株式会社 Containerized tea beverage
US20080075795A1 (en) 2006-09-20 2008-03-27 Charles Hensley Method and composition for preventing and treating avian influenza in poultry
US20080119545A1 (en) * 2006-09-21 2008-05-22 Charles Hensley Method for preventing and treating avian influenza in human
CN101524348A (en) * 2008-03-06 2009-09-09 张莉 Application of tea polyphenol in preparing medicament for treating tumor
JP5336340B2 (en) * 2009-12-09 2013-11-06 花王株式会社 Method for producing purified tea extract
CN105039298A (en) * 2015-07-02 2015-11-11 曹庸 Preparation method of immobilized tannase
CN105219815A (en) * 2015-11-06 2016-01-06 湖北中鑫生物科技有限公司 A kind of preparation method of epicatechin monomers
US20210299034A1 (en) * 2018-08-06 2021-09-30 Conopco, Inc., D/B/A Unilever A Topical Composition
CN110917146A (en) * 2019-12-03 2020-03-27 黑龙江福和制药集团股份有限公司 Thiotepa powder injection and preparation method thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3812266A (en) * 1972-01-31 1974-05-21 Lipton T Inc Green tea conversion using tannase and natural tea enzymes
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4891231A (en) * 1983-12-15 1990-01-02 Nestec S.A. Process for inhibiting liquid oxidation in food
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4710384A (en) 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
JPH01268683A (en) * 1988-04-20 1989-10-26 Mitsui Norin Kk Production of catechins having enhanced antioxidant power
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (en) 1989-03-22 1991-07-25 Bioresearch Spa USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
JPH07112404B2 (en) * 1992-05-08 1995-12-06 協同組合ティーライフクリエイティブ How to make green tea
US5605929A (en) 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5391568A (en) 1992-07-10 1995-02-21 American Health Foundation Inhibition of lung tumorigenesis by administration of a polyphenol
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5605810A (en) 1994-04-05 1997-02-25 Purdue Research Foundation NADH oxidase assay for neoplasia determination
IT1270594B (en) 1994-07-07 1997-05-07 Recordati Chem Pharm CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN
IT1275905B1 (en) 1995-03-14 1997-10-24 Indena Spa POLYPHENOLIC FRACTIONS OF TEA, THEIR USE AND FORMULATIONS THAT CONTAIN THEM
JPH1036260A (en) 1996-07-18 1998-02-10 Mitsui Norin Kk Enhancement of effect of anticancer agent
US5968973A (en) 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
US6210679B1 (en) 1999-01-07 2001-04-03 Hauser, Inc. Method for isolation of caffeine-free catechins from green tea
WO2000057875A1 (en) * 1999-03-30 2000-10-05 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors

Also Published As

Publication number Publication date
WO2001072319A1 (en) 2001-10-04
US6428818B1 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
AU2000278445A1 (en) Tea catechin formulations and processes for making same
AU5041000A (en) An effervescent green tea extract formulation
AU6030299A (en) Oral compositions comprising tea polyphenol
AU2778801A (en) Antisense compositions and methods
AU9517301A (en) Implant
AU2001294192A1 (en) Solid preparations
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2023301A (en) Improved prosthesis
AU2001295657A1 (en) Formulation containing wax-esters
AU2001263841A1 (en) Implant
AU2001234278A1 (en) Iron powder and method for the preparation thereof
AU2001262691A1 (en) Cosmetic preparation
AU2001283845A1 (en) Flavour composition
AU2001267707A1 (en) Antiperspirant formulations
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001222986A1 (en) Dehydroascorbic acid formulations and uses thereof
AU2001267693A1 (en) Antiperspirant formulations
AU2001295855A1 (en) Chocolate spread
AU2001240557A1 (en) Implant for cranioplastics
AU2001294246A1 (en) Novel aliphatic compounds, process for their preparation and their usage
AU4085201A (en) Pharmaceutical composition
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2001288102A1 (en) Solid preparations